Header title

Print Friendly, PDF & Email

Potential claim against Tesco expression of interest form

Rosenblatt is putting together a list of potential claimants for an action against Tesco plc as a result of its market abuse between 2013-2015. Tesco intentionally manipulated its trading profits and as a result many investors suffered economic loss. We believe the FCA compensation scheme does not extend far enough.  If you bought and/or sold Tesco shares or bonds during this period, and are interested in being part of a group to bring a claim,  please complete the adjacent form.

If you have any questions regarding submitting your expression of interest please email infotescoteam@rosenblatt-law.co.uk for further assistance

Please fill in this form:

Title (required)

First Name (required)

Last Name (required)

Your Email (required)

Address (required)

Date of birth (required)

Name of holding entity of shares/bonds if applicable

Address of holding entity of shares/bonds if applicable:

Type of stock (select the answer that applies):

Number of shares purchased:

Price paid:

Date/s purchased:

Price per share:

If you hold any bonds, are they in the relevant list?:

If so:

Number of bonds purchased:

Date/s purchased:

Price paid:

Have your shares/ bonds been sold?:

If yes, date the shares / bonds were sold (if applicable):

Sold price (if applicable):

© Rosenblatt Solicitors 2017
Rosenblatt is authorised and regulated by the Solicitors Regulation Authority (SRA No. 00070109). The registered address and principal place of business is 9-13 St. Andrew Street, London EC4A 3AF.
You can access the rules by which we are regulated by following this link - www.sra.org.uk/solicitors/code-of-conduct.page. Rosenblatt is registered for Value Added Tax in the United Kingdom under registration number GB 523 0713 85.

Latest news

  • Rosenblatt acted for Revelan Holdings Limited and the wider Revelan Group, a group of property investment and development companies, on a group reorganisation, redemption of intra-group loans and a new equity investment by Ares Management.
    17/10/2017
  • Rosenblatt supports Target Ovarian Cancer’s TAKE OVAR campaign
    12/10/2017
  • Rosenblatt hosts a delegation of Chinese law firms during their visit to London.
    07/09/2017